Pretax income is the income that a company earns before paying income taxes. Vycor Medical's pretax income for the
three
months ended in Dec. 2023 was $-0.09 Mil.
Its pretax income for the trailing twelve months (TTM) ended in Dec. 2023 was $-0.06 Mil.
Vycor Medical's pretax margin was -29.22%.
During the past 13 years, Vycor Medical's highest Pretax Margin was -4.24%. The lowest was -324.00%. And the median was -80.72%.
Vycor Medical Pre-Tax Income Historical Data
The historical data trend for Vycor Medical's Pre-Tax Income can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Competitive Comparison of Vycor Medical's Pre-Tax Income
For the Medical Devices subindustry, Vycor Medical's Pre-Tax Income, along with its competitors' market caps and Pre-Tax Income data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Vycor Medical's Pre-Tax Income Distribution in the Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Vycor Medical's Pre-Tax Income distribution charts can be found below:
* The bar in red indicates where Vycor Medical's Pre-Tax Income falls into.
Vycor Medical Pre-Tax Income Calculation
This is the income that a company earns before paying income taxes.
Vycor Medical's Pretax Income for the fiscal year that ended in Dec. 2023 is calculated as
Pre-Tax Income for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.06 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical (OTCPK:VYCO) Pre-Tax Income Explanation
Vycor Medical's Pretax Margin for the quarter that ended in Dec. 2023 is calculated as
During the past 13 years, Vycor Medical's highest Pretax Margin was -4.24%. The lowest was -324.00%. And the median was -80.72%.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Vycor Medical Pre-Tax Income Related Terms
Thank you for viewing the detailed overview of Vycor Medical's Pre-Tax Income provided by GuruFocus.com. Please click on the following links to see related term pages.
Vycor Medical (Vycor Medical) Business Description
Vycor Medical Inc is engaged in designing, developing and marketing medical devices for use in neurosurgery in the United States. It has developed ViewSite Brain Access System, which helps to reduce brain tissue trauma that arises from excessive pressure at the edges of the blade. It also provides non-invasive rehabilitation therapies for patients having disorders resulting from neurological brain damage caused by a stroke. The company operates through two segments: Vycor Medical, which focuses on devices for neurosurgery; and NovaVision, which focuses on neurostimulation therapies and diagnostic devices for the treatment and screening of visual field loss. The majority of the revenue comes from the Vycor Medical segment in the United States.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
Portfolio Contest
VYCO has been successfully added to your 